🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on the fourteenth of October at 51 years old after a private battle with pancreatic malignancy.

“The brilliant light of our household has dimmed his light for us in this life,” his family confirmed. “After a lengthy and courageous battle with the disease, we are deeply saddened to declare that Michael D’Angelo Archer, recognized by his followers around the world as D’Angelo, has been called home.”

D’Angelo left an indelible mark on the music industry with his innovative modern soul style and collaborations with renowned musicians.

He launched his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The album reached No. 4 on the R&B charts, earned platinum status soon after, and received multiple Grammy nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that boosted his music career into the stratosphere. The album premiered at the top spot on both the R&B charts and the main album chart. He received two Grammy Awards: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a icon, albeit a hesitant one, in the cultural zeitgeist. The intimate portrayal featured the artist, notably bare to his waist, performing straight into the lens.

D’Angelo retreated from the spotlight after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a severe car crash that left him in grave health.

More than a decade later, his last record, “Black Messiah” (2014), confirmed his enduring appeal with another top chart entry on the soul music rankings and a Grammy for Top R&B Record.

Once more, in his own enigmatic way, D’Angelo had limited public appearances in the following years.

The singer was scheduled as a top act for the 2025 music event, but his performance was called off, citing an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s well-being in the weeks before his death, he had reportedly been in the hospital for an extended period and in hospice for a fortnight.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic malignancy, one of the deadliest and least preventable types of the disease, on a brilliant talent whose existence was ended too soon.

“We are grieved that he can only provide cherished moments with his family, but we are forever thankful for the heritage of extraordinarily moving songs he has left us,” his kin expressed.

Pancreatic Cancer: Deadly and Rarely Preventable

Pancreatic cancer affects the pancreas, a tiny gland that generates insulin and is vital in digestion, among other functions. The position and dimensions of the pancreas in the human system make it more difficult to identify cancer.

Although this cancer makes up only approximately three percent of malignancy cases annually in the U.S., it is responsible for seven percent of malignancy fatalities.

Almost 70,000 individuals will be diagnosed with this condition and roughly fifty-two thousand will die of the disease in 2025.

“This malignancy is one of the deadliest cancers, with an fast-growing mass and poor prognosis. We have few and poor therapies, and a narrow opportunity to make a meaningful impact on the well-being of people,” said a cancer specialist.

Since this disease rarely causes initial signs, it’s often diagnosed only after the disease is advanced. Although a patient has indicators they are often nonspecific and may be mistaken for a several common illnesses.

“As of yet, there is no effective method to identify pancreatic cancer in the initial phases, except for paying attention to physical changes and speaking with your physician if there are new or unusual signs,” explained a medical director.

Common symptoms of pancreatic cancer include:

• abdominal or lower back pain
• weight loss
• jaundice
• loss of appetite
• brownish urine
• light-colored or greasy stools
• loose stools
• excessive hunger or thirst
• feeling sick

At age 51, D’Angelo’s death is an exception, as this malignancy is typically found in adults in the sixty-five to seventy-five age bracket. However, many cancers, such as pancreatic cancer, have become more common in younger adults.

“Pancreatic cancer diagnosed before the age of 50 is considered rare, yet concerningly, doctors are noticing a growing number of younger patients affected by this disease,” commented a specialist.

Family History Affects Cancer Risk

Without reliable screening tools for pancreatic cancer, professionals emphasized the significance of knowing your relatives’ cancer history. Certain risk factors, such as smoking and obesity also have an influence in the development of pancreatic cancer.

Black individuals have the greatest occurrence of this malignancy in the United States and are more prone to be diagnosed with untreatable disease.

“The first step toward reducing one’s risk of pancreatic cancer is understanding individual susceptibility. People should examine their family history, hereditary factors, and medical conditions, such as blood sugar disease, chronic pancreatitis, or overweight that may increase their susceptibility,” said a medical professional.

Inherited genetic elements are associated with as much as ten percent of all pancreatic cancer cases. If a relative in your family has had this disease, you may want to consider genetic testing.

“For individuals with a family history of pancreatic cancer or those having elevated risk DNA changes, checking may involve sophisticated scans such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to detect initial alterations in the organ,” he clarified.

For those wishing to lower their chance, habit adjustments may make a difference. The most effective step you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you don’t smoke, avoid exposure altogether.

Excessive drinking is associated with pancreatitis, a contributing element for this malignancy, so limiting or abstaining from alcohol may assist reduce your risk.

Controlling your weight or shedding pounds may also help decrease your susceptibility. People with excess weight are twenty percent more prone to develop this disease. This malignancy also occurs more often in people with diabetes, and reducing weight can also reduce the risk of type 2 diabetes.

Despite this disease’s poor prognosis, there is reason for optimism.

“We are making progress with therapies and newer mixed drug treatments. There are emerging targeted therapies that already are making an impact,” remarked a specialist.

For numerous people, however, awareness about this rare but {dev